Frequently Asked Questions
The market is segmented based on , By Product (Single-Layer Drug-In-Adhesive, Multi-Layer Drug-In-Adhesive, Matrix, Reservoir, Vapor, and Others), Type (Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Buprenorphine Transdermal Patch, Clonidine Transdermal Patch, Oxybutynin Transdermal Patch, and Others), Application (Cardiovascular Disorder, Central Nervous System Disorders (CNS), Pain Management/ Relief, Smoking Reduction and Cessation Aid, Overactive Bladder, Nicotine Cessation, Hormonal Therapy/ Disorders, Dermatology, and Others), Technology (Electric Current, Mechanical Arrays, Thermal Ablation, Chemical Enhancers, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), End user (Home Care Settings, Hospitals, and Clinics) – Industry Trends and Forecast to 2031.
.
The Global Transdermal Patches Market size was valued at USD 7.48 USD Billion in 2023.
The Global Transdermal Patches Market is projected to grow at a CAGR of 4.9% during the forecast period of 2024 to 2031.
The major players operating in the market include , AdhexPharma , ProSolus , tesa SE , Nitto Denko Corporation. , Noven Pharmaceuticals , LTS Lohmann Therapie,Systeme AG , Medherant Limited , Corium LLC. , Bayer AG , Novartis AG , Antares Pharma , Abbott. , Mylan N.V. , Acrux Limited , Sparsha Pharma International Pvt Ltd , Bliss GVS Pharma. , Johnson & Johnson Services , Informa Connect Limited .
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina and rest of South America.
